$60,000 of JOHNSON & JOHNSON SERVICES INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Pharmacy Benefit Managers. 340B. Tort Litigation reform. Health care supply chain. S.864 - HELP Copays Act. Inflation Reduction Act Implementation."
You can find more data on corporate lobbying on Quiver Quantitative.
JNJ Congressional Stock Trading
Members of Congress have traded $JNJ stock 15 times in the past 6 months. Of those trades, 5 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 08/19.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/04, 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 07/31.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 06/12.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 06/10.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/30 and 1 sale worth up to $15,000 on 04/29.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
JNJ Insider Trading Activity
JNJ insiders have traded $JNJ stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOAQUIN DUATO (CEO and Chairman of the Board) sold 125,824 shares for an estimated $22,548,654
- JENNIFER L TAUBERT (EVP, WWC. Innovative Medicine) sold 56,471 shares for an estimated $10,040,882
- JOHN C REED (EVP, Innovative Medicine, R&D) sold 19,137 shares for an estimated $3,129,829
- JOSEPH J WOLK (Exec VP, CFO) sold 16,820 shares for an estimated $2,975,570
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JNJ Hedge Fund Activity
We have seen 1,708 institutional investors add shares of JNJ stock to their portfolio, and 2,043 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 4,482,323 shares (+2.2%) to their portfolio in Q2 2025, for an estimated $684,674,838
- INVESCO LTD. removed 4,457,751 shares (-24.1%) from their portfolio in Q2 2025, for an estimated $680,921,465
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,319,402 shares (+20.3%) to their portfolio in Q2 2025, for an estimated $507,038,655
- CAPITAL INTERNATIONAL INVESTORS removed 3,101,458 shares (-83.8%) from their portfolio in Q2 2025, for an estimated $473,747,709
- VANGUARD GROUP INC added 3,085,180 shares (+1.3%) to their portfolio in Q2 2025, for an estimated $471,261,245
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 2,476,715 shares (+inf%) to their portfolio in Q2 2025, for an estimated $378,318,216
- WELLINGTON MANAGEMENT GROUP LLP added 2,230,577 shares (+9.8%) to their portfolio in Q2 2025, for an estimated $340,720,636
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JNJ Analyst Ratings
Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/07/2025
- Wells Fargo issued a "Overweight" rating on 10/03/2025
- RBC Capital issued a "Outperform" rating on 07/17/2025
- UBS issued a "Buy" rating on 07/17/2025
To track analyst ratings and price targets for JNJ, check out Quiver Quantitative's $JNJ forecast page.
JNJ Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 12 analysts offer price targets for $JNJ in the last 6 months, with a median target of $195.5.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $178.0 on 10/10/2025
- Asad Haider from Goldman Sachs set a target price of $212.0 on 10/09/2025
- Joanne Wuensch from Citigroup set a target price of $213.0 on 10/07/2025
- Lee Hambright from Bernstein set a target price of $193.0 on 10/06/2025
- Larry Biegelsen from Wells Fargo set a target price of $212.0 on 10/03/2025
- Tim Anderson from B of A Securities set a target price of $198.0 on 10/03/2025
- Vamil Divan from Guggenheim set a target price of $206.0 on 09/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
